Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhib...

by Jian-Guo Zhou, Benjamin Frey, Hu Ma, Markus Hecht, Sandra Rutzner, Ina Becker, Rainer Fietkau, Udo Gaipl, Anna-Jasmina Donaubauer, Philipp Schubert, Claudia Schweizer
Published 2021-02-01

Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors

by Philipp Schubert, Philipp Schubert, Sandra Rutzner, Sandra Rutzner, Markus Eckstein, Markus Eckstein, Benjamin Frey, Benjamin Frey, Claudia Schweizer, Claudia Schweizer, Marlen Haderlein, Marlen Haderlein, Sebastian Lettmaier, Sebastian Lettmaier, Sabine Semrau, Sabine Semrau, Antoniu-Oreste Gostian, Antoniu-Oreste Gostian, Jian-Guo Zhou, Jian-Guo Zhou, Jian-Guo Zhou, Udo S. Gaipl, Udo S. Gaipl, Rainer Fietkau, Rainer Fietkau, Markus Hecht, Markus Hecht
Published 2020-10-01

Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

by Luisa Maria Griewing, Claudia Schweizer, Philipp Schubert, Sandra Rutzner, Markus Eckstein, Benjamin Frey, Marlen Haderlein, Thomas Weissmann, Sabine Semrau, Antoniu-Oreste Gostian, Sarina K. Müller, Maximilian Traxdorf, Heinrich Iro, Jian-Guo Zhou, Udo S. Gaipl, Rainer Fietkau, Markus Hecht
Published 2021-03-01